SARS-CoV-2 mRNA vaccinations fail to elicit humoral and cellular immune responses in patients with multiple sclerosis receiving fingolimod
Article
Published on
Journal: Journal of neurology, neurosurgery, and psychiatry
[Category] COVID19(2023년), SARS, 진단,
Journal: Journal of neurology, neurosurgery, and psychiatry
[Category] COVID19(2023년), SARS, 진단,
[키워드] absence
Acetate
Alter
analysed
antagonist
approved
Autoimmune diseases
B cell
B cells
booster
booster vaccinations
CD4
Cellular immune response
clinical neurology
elicit
elicited
fumarate
functional immune response
healthy individual
homologous
humoral
humoral immune response
IgG
Immune cell
immunogenic
immunology
Infection
Infectious diseases
investigated
lack
Measures
mRNA
mRNA vaccination
mRNA vaccine
multiple sclerosis
multiple sclerosis.
Neutralising activity
Patient
patients
Peripheral blood
prospective cohort study
Protective
receiving
receptor
Receptor binding
reduced
risk
SARS-CoV-2
serum
severe COVID-19
severe SARS-CoV-2
stability
T cell
T cell response
T cell responses
therapy
these cell
Treatment
vaccination
Vaccinations
vaccine-specific antibodies
[DOI] 10.1136/jnnp-2022-329395 PMC 바로가기
[DOI] 10.1136/jnnp-2022-329395 PMC 바로가기